I agree. It needs to be way punchier. Just need to draw people in with cliff notes. I think something along these lines:
-We are Race Oncology our total market potential is XYZ
-We are way more de-risked than a typical biotech for xyz reasons
-Better yet we have 3 shots on goal, 2 of them are massive opportunities, and 1 legacy opportunity, which we've already jumped through all the hoops for before
-We are drastically undervalued and have some upcoming catalysts, which we have enough cash on hand to arrive to
The above is all factual, it's clear, it's easy to grasp for a layman and can be delivered in under a minute. Ultimately I think retail punters are looking for a few key things in biotech...cash on hand, upcoming catalysts, and a big potential market. Let them go down the rabbit hole after they realise why they should be excited.
RAC media coverage, page-1865
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.75 |
Change
0.010(0.57%) |
Mkt cap ! $298.0M | |||
| Open | High | Low | Value | Volume |
| $1.73 | $1.83 | $1.73 | $272.0K | 152.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9998 | $1.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.79 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |